Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical...

Nicolò Bizzarri¹, Lukáš Dostálek, Luc R C W van Lonkhuijzen+29

• ¹UOC Ginecologia Oncologica, Dipartimento per la Salute della Donna e del Bambino e della Salute Pubblica, and the Biostatistics Unit, Scientific Directorate, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, and the University of Milano-Bicocca, Department of Obstetrics and Gynecology, Gynaecologic Oncology Surgical Unit, ASST-Monza, San Gerardo Hospital, Monza, Italy; the Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital (Central and Eastern European Gynecologic Oncology Group, CEEGOG), and the Department of Gynaecology and Obstetrics, University Hospital Pilsen, Charles University, Prague, the Department of Obstetrics and Gynecology, Faculty of Medicine, University Hospital and University of Ostrava, Ostrava, and the University Hospital Brno, Medical Faculty of Masaryk University, Brno, Czech Republic; the Center for Gynaecologic Oncology Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands; the Department of Gynecological Surgery, National Institute of Neoplastic Diseases, Lima, Peru; the Department of Pelvic Cancer, Karolinska University Hospital and Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; the Baskent University School of Medicine, Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, and the Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health and Research Hospital, University of Health Sciences, Ankara, Turkey; Memorial Sloan Kettering Cancer Center, New York, New York; the Gynecology Oncology Center, National Institute of Cancerology Mexico, Mexico City, Mexico; the Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Bogotá, Colombia; the Wolfson Institute of Preventive Medicine, Barts Cancer Centre, Queen Mary University of London, & Barts Health NHS Trust, London, United Kingdom; the Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; the Department of Gynecologic Oncology, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano, Buenos Aires, Argentina; Gynecology, Medical University of Graz, Graz, Austria; the Gynecologic Oncology Unit, La Paz University Hospital - IdiPAZ, Madrid, Spain; and the Department of Gynecologic Oncology, Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil.